APO Research
Talk to an analyst

APO RESEARCH · REPORT

Virtual Screening Technology Service

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Virtual Screening Technology Service Market Outlook and Growth Opportunities 2026

12 August 2026219 pages

Choose your research edition.

Industry ResearchVirtual Screening Technology Service Industry Research Report 2026140 pages · $2,950 USDIndustry Growth & TrendsGlobal Virtual Screening Technology Service Industry Growth and Trends Forecast to 2032122 pages · $3,450 USDMarket StructureGlobal Virtual Screening Technology Service Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Virtual Screening Technology Service Market Outlook and Growth Opportunities 2026219 pages · $4,250 USDMarket Analysis & ForecastGlobal Virtual Screening Technology Service Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Virtual Screening Technology Service market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Virtual Screening Technology Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Virtual Screening Technology Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Virtual Screening Technology Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Virtual Screening Technology Service market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Virtual Screening Technology Service market include XtalPi, Insilico Medicine, Sygnature Discovery, Charles River, Pharmaron, Evotec, Cresset Group, BioSoIvelT and Enamine, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Virtual Screening Technology Service market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Virtual Screening Technology Service and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Virtual Screening Technology Service revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Virtual Screening Technology Service market.

Virtual Screening Technology Service Segment by Company

XtalPi

Insilico Medicine

Sygnature Discovery

Charles River

Pharmaron

Evotec

Cresset Group

BioSoIvelT

Enamine

Aurigene Services

Selvita

HITS

Standigm

Syntekabio

Pharmacelera

Receptor.AI

Chemspace

Jubilant Biosys

Aragen

Domainex

NUVISAN

Concept Life Sciences

Schrödinger

Cadence

WuXi AppTec

Virtual Screening Technology Service Segment by Type

Structure-Based Virtual Screening

Ligand-Based Virtual Screening

Others

Virtual Screening Technology Service Segment by Application

Pharmaceutical Industry

Biotechnology Industry

Academic Research Institutions

Others

Virtual Screening Technology Service Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Virtual Screening Technology Service status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Virtual Screening Technology Service key companies, revenue, market share, and recent developments.

3. To split the Virtual Screening Technology Service breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Virtual Screening Technology Service market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Virtual Screening Technology Service significant trends, drivers, influence factors in global and regions.

6. To analyze Virtual Screening Technology Service competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Virtual Screening Technology Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Virtual Screening Technology Service and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Virtual Screening Technology Service.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Virtual Screening Technology Service industry.

Chapter 3: Detailed analysis of Virtual Screening Technology Service company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Virtual Screening Technology Service in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Virtual Screening Technology Service in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Virtual Screening Technology Service Industry Trends Table 2. Virtual Screening Technology Service Industry Drivers Table 3. Virtual Screening Technology Service Industry Opportunities and Challenges Table 4. Virtual Screening Technology Service Industry Restraints Table 5. Global Virtual Screening Technology Service Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Virtual Screening Technology Service Revenue Share by Company (2021-2026) Table 7. Global Virtual Screening Technology Service Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Virtual Screening Technology Service Key Company Manufacturing Base & Headquarters Table 9. Global Virtual Screening Technology Service Company, Product Type & Application Table 10. Global Virtual Screening Technology Service Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Virtual Screening Technology Service by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Structure-Based Virtual Screening Table 15. Significant Companies of Ligand-Based Virtual Screening Table 16. Significant Companies of Others Table 17. Global Virtual Screening Technology Service Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 18. Global Virtual Screening Technology Service Sales Value by Type (2021-2026) & (US$ Million) Table 19. Global Virtual Screening Technology Service Sales Value by Type (2027-2032) & (US$ Million) Table 20. Global Virtual Screening Technology Service Sales Value Share by Type (2021-2026) Table 21. Global Virtual Screening Technology Service Sales Value Share by Type (2027-2032) Table 22. Significant Companies of Pharmaceutical Industry Table 23. Significant Companies of Biotechnology Industry Table 24. Significant Companies of Academic Research Institutions Table 25. Significant Companies of Others Table 26. Global Virtual Screening Technology Service Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Virtual Screening Technology Service Sales Value by Application (2021-2026) & (US$ Million) Table 28. Global Virtual Screening Technology Service Sales Value by Application (2027-2032) & (US$ Million) Table 29. Global Virtual Screening Technology Service Sales Value Share by Application (2021-2026) Table 30. Global Virtual Screening Technology Service Sales Value Share by Application (2027-2032) Table 31. Global Virtual Screening Technology Service Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Virtual Screening Technology Service Sales Value by Region (2021-2026) & (US$ Million) Table 33. Global Virtual Screening Technology Service Sales Value Share by Region (2021-2026) Table 34. Global Virtual Screening Technology Service Sales Value by Region (2027-2032) & (US$ Million) Table 35. Global Virtual Screening Technology Service Sales Value Share by Region (2027-2032) Table 36. Global Virtual Screening Technology Service Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Virtual Screening Technology Service Sales Value by Country (2021-2026) & (US$ Million) Table 38. Global Virtual Screening Technology Service Sales Value Market Share by Country (2021-2026) Table 39. Global Virtual Screening Technology Service Sales Value by Country (2027-2032) & (US$ Million) Table 40. Global Virtual Screening Technology Service Sales Value Market Share by Country (2027-2032) Table 41. XtalPi Company Information Table 42. XtalPi Business Overview Table 43. XtalPi Virtual Screening Technology Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 44. XtalPi Virtual Screening Technology Service Product Portfolio Table 45. XtalPi Recent Development Table 46. Insilico Medicine Company Information Table 47. Insilico Medicine Business Overview Table 48. Insilico Medicine Virtual Screening Technology Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 49. Insilico Medicine Virtual Screening Technology Service Product Portfolio Table 50. Insilico Medicine Recent Development Table 51. Sygnature Discovery Company Information Table 52. Sygnature Discovery Business Overview Table 53. Sygnature Discovery Virtual Screening Technology Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 54. Sygnature Discovery Virtual Screening Technology Service Product Portfolio Table 55. Sygnature Discovery Recent Development Table 56. Charles River Company Information Table 57. Charles River Business Overview Table 58. Charles River Virtual Screening Technology Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 59. Charles River Virtual Screening Technology Service Product Portfolio Table 60. Charles River Recent Development Table 61. Pharmaron Company Information Table 62. Pharmaron Business Overview Table 63. Pharmaron Virtual Screening Technology Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 64. Pharmaron Virtual Screening Technology Service Product Portfolio Table 65. Pharmaron Recent Development Table 66. Evotec Company Information Table 67. Evotec Business Overview Table 68. Evotec Virtual Screening Technology Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 69. Evotec Virtual Screening Technology Service Product Portfolio Table 70. Evotec Recent Development Table 71. Cresset Group Company Information Table 72. Cresset Group Business Overview Table 73. Cresset Group Virtual Screening Technology Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 74. Cresset Group Virtual Screening Technology Service Product Portfolio Table 75. Cresset Group Recent Development Table 76. BioSoIvelT Company Information Table 77. BioSoIvelT Business Overview Table 78. BioSoIvelT Virtual Screening Technology Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 79. BioSoIvelT Virtual Screening Technology Service Product Portfolio Table 80. BioSoIvelT Recent Development Table 81. Enamine Company Information Table 82. Enamine Business Overview Table 83. Enamine Virtual Screening Technology Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 84. Enamine Virtual Screening Technology Service Product Portfolio Table 85. Enamine Recent Development Table 86. Aurigene Services Company Information Table 87. Aurigene Services Business Overview Table 88. Aurigene Services Virtual Screening Technology Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 89. Aurigene Services Virtual Screening Technology Service Product Portfolio Table 90. Aurigene Services Recent Development Table 91. Selvita Company Information Table 92. Selvita Business Overview Table 93. Selvita Virtual Screening Technology Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 94. Selvita Virtual Screening Technology Service Product Portfolio Table 95. Selvita Recent Development Table 96. HITS Company Information Table 97. HITS Business Overview Table 98. HITS Virtual Screening Technology Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 99. HITS Virtual Screening Technology Service Product Portfolio Table 100. HITS Recent Development Table 101. Standigm Company Information Table 102. Standigm Business Overview Table 103. Standigm Virtual Screening Technology Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 104. Standigm Virtual Screening Technology Service Product Portfolio Table 105. Standigm Recent Development Table 106. Syntekabio Company Information Table 107. Syntekabio Business Overview Table 108. Syntekabio Virtual Screening Technology Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 109. Syntekabio Virtual Screening Technology Service Product Portfolio Table 110. Syntekabio Recent Development Table 111. Pharmacelera Company Information Table 112. Pharmacelera Business Overview Table 113. Pharmacelera Virtual Screening Technology Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 114. Pharmacelera Virtual Screening Technology Service Product Portfolio Table 115. Pharmacelera Recent Development Table 116. Receptor.AI Company Information Table 117. Receptor.AI Business Overview Table 118. Receptor.AI Virtual Screening Technology Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 119. Receptor.AI Virtual Screening Technology Service Product Portfolio Table 120. Receptor.AI Recent Development Table 121. Chemspace Company Information Table 122. Chemspace Business Overview Table 123. Chemspace Virtual Screening Technology Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 124. Chemspace Virtual Screening Technology Service Product Portfolio Table 125. Chemspace Recent Development Table 126. Jubilant Biosys Company Information Table 127. Jubilant Biosys Business Overview Table 128. Jubilant Biosys Virtual Screening Technology Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 129. Jubilant Biosys Virtual Screening Technology Service Product Portfolio Table 130. Jubilant Biosys Recent Development Table 131. Aragen Company Information Table 132. Aragen Business Overview Table 133. Aragen Virtual Screening Technology Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 134. Aragen Virtual Screening Technology Service Product Portfolio Table 135. Aragen Recent Development Table 136. Domainex Company Information Table 137. Domainex Business Overview Table 138. Domainex Virtual Screening Technology Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 139. Domainex Virtual Screening Technology Service Product Portfolio Table 140. Domainex Recent Development Table 141. NUVISAN Company Information Table 142. NUVISAN Business Overview Table 143. NUVISAN Virtual Screening Technology Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 144. NUVISAN Virtual Screening Technology Service Product Portfolio Table 145. NUVISAN Recent Development Table 146. Concept Life Sciences Company Information Table 147. Concept Life Sciences Business Overview Table 148. Concept Life Sciences Virtual Screening Technology Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 149. Concept Life Sciences Virtual Screening Technology Service Product Portfolio Table 150. Concept Life Sciences Recent Development Table 151. Schrödinger Company Information Table 152. Schrödinger Business Overview Table 153. Schrödinger Virtual Screening Technology Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 154. Schrödinger Virtual Screening Technology Service Product Portfolio Table 155. Schrödinger Recent Development Table 156. Cadence Company Information Table 157. Cadence Business Overview Table 158. Cadence Virtual Screening Technology Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 159. Cadence Virtual Screening Technology Service Product Portfolio Table 160. Cadence Recent Development Table 161. WuXi AppTec Company Information Table 162. WuXi AppTec Business Overview Table 163. WuXi AppTec Virtual Screening Technology Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 164. WuXi AppTec Virtual Screening Technology Service Product Portfolio Table 165. WuXi AppTec Recent Development Table 166. Research Programs/Design for This Report Table 167. Authors List of This Report Table 168. Secondary Sources Table 169. Primary Sources List of Figures Figure 1. Virtual Screening Technology Service Product Image Figure 2. Global Virtual Screening Technology Service Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Virtual Screening Technology Service Market Size (2021-2032) & (US$ Million) Figure 4. Global Virtual Screening Technology Service Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Structure-Based Virtual Screening Image Figure 8. Ligand-Based Virtual Screening Image Figure 9. Others Image Figure 10. Global Virtual Screening Technology Service Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 11. Global Virtual Screening Technology Service Sales Value Share 2021 VS 2025 VS 2032 Figure 12. Global Virtual Screening Technology Service Sales Value Share by Type (2021-2032) Figure 13. Pharmaceutical Industry Image Figure 14. Biotechnology Industry Image Figure 15. Academic Research Institutions Image Figure 16. Others Image Figure 17. Global Virtual Screening Technology Service Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Virtual Screening Technology Service Sales Value Share 2021 VS 2025 VS 2032 Figure 19. Global Virtual Screening Technology Service Sales Value Share by Application (2021-2032) Figure 20. Global Virtual Screening Technology Service Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 21. Global Virtual Screening Technology Service Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 22. North America Virtual Screening Technology Service Sales Value (2021-2032) & (US$ Million) Figure 23. North America Virtual Screening Technology Service Sales Value Share by Country (%), 2025 VS 2032 Figure 24. Europe Virtual Screening Technology Service Sales Value (2021-2032) & (US$ Million) Figure 25. Europe Virtual Screening Technology Service Sales Value Share by Country (%), 2025 VS 2032 Figure 26. Asia-Pacific Virtual Screening Technology Service Sales Value (2021-2032) & (US$ Million) Figure 27. Asia-Pacific Virtual Screening Technology Service Sales Value Share by Country (%), 2025 VS 2032 Figure 28. South America Virtual Screening Technology Service Sales Value (2021-2032) & (US$ Million) Figure 29. South America Virtual Screening Technology Service Sales Value Share by Country (%), 2025 VS 2032 Figure 30. Middle East & Africa Virtual Screening Technology Service Sales Value (2021-2032) & (US$ Million) Figure 31. Middle East & Africa Virtual Screening Technology Service Sales Value Share by Country (%), 2025 VS 2032 Figure 32. USA Virtual Screening Technology Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 33. USA Virtual Screening Technology Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 34. USA Virtual Screening Technology Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 35. Canada Virtual Screening Technology Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 36. Canada Virtual Screening Technology Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 37. Canada Virtual Screening Technology Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 38. Mexico Virtual Screening Technology Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 39. Mexico Virtual Screening Technology Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 40. Mexico Virtual Screening Technology Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 41. Germany Virtual Screening Technology Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. Germany Virtual Screening Technology Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. Germany Virtual Screening Technology Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. France Virtual Screening Technology Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. France Virtual Screening Technology Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. France Virtual Screening Technology Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. U.K. Virtual Screening Technology Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. U.K. Virtual Screening Technology Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. U.K. Virtual Screening Technology Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Italy Virtual Screening Technology Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Italy Virtual Screening Technology Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Italy Virtual Screening Technology Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. Spain Virtual Screening Technology Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. Spain Virtual Screening Technology Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. Spain Virtual Screening Technology Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. Russia Virtual Screening Technology Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. Russia Virtual Screening Technology Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. Russia Virtual Screening Technology Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Netherlands Virtual Screening Technology Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Netherlands Virtual Screening Technology Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Netherlands Virtual Screening Technology Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Nordic Countries Virtual Screening Technology Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Nordic Countries Virtual Screening Technology Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Nordic Countries Virtual Screening Technology Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. China Virtual Screening Technology Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. China Virtual Screening Technology Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. China Virtual Screening Technology Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Japan Virtual Screening Technology Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Japan Virtual Screening Technology Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Japan Virtual Screening Technology Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. South Korea Virtual Screening Technology Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. South Korea Virtual Screening Technology Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. South Korea Virtual Screening Technology Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. India Virtual Screening Technology Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. India Virtual Screening Technology Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. India Virtual Screening Technology Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Australia Virtual Screening Technology Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Australia Virtual Screening Technology Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Australia Virtual Screening Technology Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. Southeast Asia Virtual Screening Technology Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. Southeast Asia Virtual Screening Technology Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. Southeast Asia Virtual Screening Technology Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. Brazil Virtual Screening Technology Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. Brazil Virtual Screening Technology Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. Brazil Virtual Screening Technology Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Argentina Virtual Screening Technology Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Argentina Virtual Screening Technology Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Argentina Virtual Screening Technology Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Chile Virtual Screening Technology Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Chile Virtual Screening Technology Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Chile Virtual Screening Technology Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Colombia Virtual Screening Technology Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Colombia Virtual Screening Technology Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Colombia Virtual Screening Technology Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Peru Virtual Screening Technology Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Peru Virtual Screening Technology Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Peru Virtual Screening Technology Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Saudi Arabia Virtual Screening Technology Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Saudi Arabia Virtual Screening Technology Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Saudi Arabia Virtual Screening Technology Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Israel Virtual Screening Technology Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Israel Virtual Screening Technology Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Israel Virtual Screening Technology Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. UAE Virtual Screening Technology Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. UAE Virtual Screening Technology Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. UAE Virtual Screening Technology Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Turkey Virtual Screening Technology Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Turkey Virtual Screening Technology Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Turkey Virtual Screening Technology Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Iran Virtual Screening Technology Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Iran Virtual Screening Technology Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Iran Virtual Screening Technology Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Egypt Virtual Screening Technology Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. Egypt Virtual Screening Technology Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. Egypt Virtual Screening Technology Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Years Considered Figure 117. Research Process Figure 118. Key Executives Interviewed

Scope & coverage.

Types
  • Structure-Based Virtual Screening
  • Ligand-Based Virtual Screening
  • Others
Applications
  • Pharmaceutical Industry
  • Biotechnology Industry
  • Academic Research Institutions
  • Others
Companies covered
  • XtalPi
  • Insilico Medicine
  • Sygnature Discovery
  • Charles River
  • Pharmaron
  • Evotec
  • Cresset Group
  • BioSoIvelT
  • Enamine
  • Aurigene Services
  • Selvita
  • HITS
  • Standigm
  • Syntekabio
  • Pharmacelera
  • Receptor.AI
  • Chemspace
  • Jubilant Biosys
  • Aragen
  • Domainex
  • NUVISAN
  • Concept Life Sciences
  • Schrödinger
  • Cadence
  • WuXi AppTec

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Virtual Screening Technology Service Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Virtual Screening Technology Service Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Virtual Screening Technology Service Market Dynamics
  1. 2.1 Virtual Screening Technology Service Industry Trends
  2. 2.2 Virtual Screening Technology Service Industry Drivers
  3. 2.3 Virtual Screening Technology Service Industry Opportunities and Challenges
  4. 2.4 Virtual Screening Technology Service Industry Restraints
3 Virtual Screening Technology Service Market by Company
  1. 3.1 Global Virtual Screening Technology Service Company Revenue Ranking in 2025
  2. 3.2 Global Virtual Screening Technology Service Revenue by Company (2021-2026)
  3. 3.3 Global Virtual Screening Technology Service Company Ranking (2024-2026)
  4. 3.4 Global Virtual Screening Technology Service Company Manufacturing Base and Headquarters
  5. 3.5 Global Virtual Screening Technology Service Company Product Type and Application
  6. 3.6 Global Virtual Screening Technology Service Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Virtual Screening Technology Service Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Virtual Screening Technology Service Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Virtual Screening Technology Service Market by Type
  1. 4.1 Virtual Screening Technology Service Type Introduction
  2. 4.1.1 Structure-Based Virtual Screening
  3. 4.1.2 Ligand-Based Virtual Screening
  4. 4.1.3 Others
  5. 4.2 Global Virtual Screening Technology Service Sales Value by Type
  6. 4.2.1 Global Virtual Screening Technology Service Sales Value by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Virtual Screening Technology Service Sales Value by Type (2021-2032)
  8. 4.2.3 Global Virtual Screening Technology Service Sales Value Share by Type (2021-2032)
5 Virtual Screening Technology Service Market by Application
  1. 5.1 Virtual Screening Technology Service Application Introduction
  2. 5.1.1 Pharmaceutical Industry
  3. 5.1.2 Biotechnology Industry
  4. 5.1.3 Academic Research Institutions
  5. 5.1.4 Others
  6. 5.2 Global Virtual Screening Technology Service Sales Value by Application
  7. 5.2.1 Global Virtual Screening Technology Service Sales Value by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Virtual Screening Technology Service Sales Value by Application (2021-2032)
  9. 5.2.3 Global Virtual Screening Technology Service Sales Value Share by Application (2021-2032)
6 Virtual Screening Technology Service Regional Value Analysis
  1. 6.1 Global Virtual Screening Technology Service Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Virtual Screening Technology Service Sales Value by Region (2021-2032)
  3. 6.2.1 Global Virtual Screening Technology Service Sales Value by Region: 2021-2026
  4. 6.2.2 Global Virtual Screening Technology Service Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Virtual Screening Technology Service Sales Value (2021-2032)
  7. 6.3.2 North America Virtual Screening Technology Service Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Virtual Screening Technology Service Sales Value (2021-2032)
  10. 6.4.2 Europe Virtual Screening Technology Service Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Virtual Screening Technology Service Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Virtual Screening Technology Service Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Virtual Screening Technology Service Sales Value (2021-2032)
  16. 6.6.2 South America Virtual Screening Technology Service Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Virtual Screening Technology Service Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Virtual Screening Technology Service Sales Value Share by Country, 2025 VS 2032
7 Virtual Screening Technology Service Country-level Value Analysis
  1. 7.1 Global Virtual Screening Technology Service Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Virtual Screening Technology Service Sales Value by Country (2021-2032)
  3. 7.2.1 Global Virtual Screening Technology Service Sales Value by Country (2021-2026)
  4. 7.2.2 Global Virtual Screening Technology Service Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Virtual Screening Technology Service Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Virtual Screening Technology Service Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Virtual Screening Technology Service Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Virtual Screening Technology Service Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Virtual Screening Technology Service Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Virtual Screening Technology Service Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Virtual Screening Technology Service Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Virtual Screening Technology Service Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Virtual Screening Technology Service Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Virtual Screening Technology Service Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Virtual Screening Technology Service Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Virtual Screening Technology Service Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Virtual Screening Technology Service Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Virtual Screening Technology Service Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Virtual Screening Technology Service Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Virtual Screening Technology Service Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Virtual Screening Technology Service Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Virtual Screening Technology Service Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Virtual Screening Technology Service Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Virtual Screening Technology Service Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Virtual Screening Technology Service Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Virtual Screening Technology Service Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Virtual Screening Technology Service Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Virtual Screening Technology Service Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Virtual Screening Technology Service Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Virtual Screening Technology Service Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Virtual Screening Technology Service Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Virtual Screening Technology Service Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Virtual Screening Technology Service Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Virtual Screening Technology Service Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Virtual Screening Technology Service Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Virtual Screening Technology Service Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Virtual Screening Technology Service Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Virtual Screening Technology Service Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Virtual Screening Technology Service Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Virtual Screening Technology Service Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Virtual Screening Technology Service Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Virtual Screening Technology Service Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Virtual Screening Technology Service Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Virtual Screening Technology Service Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Virtual Screening Technology Service Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Virtual Screening Technology Service Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Virtual Screening Technology Service Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Virtual Screening Technology Service Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Virtual Screening Technology Service Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Virtual Screening Technology Service Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Virtual Screening Technology Service Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Virtual Screening Technology Service Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Virtual Screening Technology Service Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Virtual Screening Technology Service Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Virtual Screening Technology Service Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Virtual Screening Technology Service Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Virtual Screening Technology Service Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Virtual Screening Technology Service Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Virtual Screening Technology Service Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Virtual Screening Technology Service Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Virtual Screening Technology Service Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Virtual Screening Technology Service Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Virtual Screening Technology Service Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Virtual Screening Technology Service Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Virtual Screening Technology Service Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Virtual Screening Technology Service Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Virtual Screening Technology Service Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Virtual Screening Technology Service Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Virtual Screening Technology Service Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Virtual Screening Technology Service Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Virtual Screening Technology Service Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Virtual Screening Technology Service Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Virtual Screening Technology Service Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Virtual Screening Technology Service Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Virtual Screening Technology Service Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Virtual Screening Technology Service Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Virtual Screening Technology Service Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Virtual Screening Technology Service Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Virtual Screening Technology Service Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Virtual Screening Technology Service Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Virtual Screening Technology Service Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Virtual Screening Technology Service Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Virtual Screening Technology Service Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Virtual Screening Technology Service Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Virtual Screening Technology Service Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Virtual Screening Technology Service Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Virtual Screening Technology Service Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Virtual Screening Technology Service Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 XtalPi
  2. 8.1.1 XtalPi Company Information
  3. 8.1.2 XtalPi Business Overview
  4. 8.1.3 XtalPi Virtual Screening Technology Service Revenue and Gross Margin (2021-2026)
  5. 8.1.4 XtalPi Virtual Screening Technology Service Product Portfolio
  6. 8.1.5 XtalPi Recent Developments
  7. 8.2 Insilico Medicine
  8. 8.2.1 Insilico Medicine Company Information
  9. 8.2.2 Insilico Medicine Business Overview
  10. 8.2.3 Insilico Medicine Virtual Screening Technology Service Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Insilico Medicine Virtual Screening Technology Service Product Portfolio
  12. 8.2.5 Insilico Medicine Recent Developments
  13. 8.3 Sygnature Discovery
  14. 8.3.1 Sygnature Discovery Company Information
  15. 8.3.2 Sygnature Discovery Business Overview
  16. 8.3.3 Sygnature Discovery Virtual Screening Technology Service Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Sygnature Discovery Virtual Screening Technology Service Product Portfolio
  18. 8.3.5 Sygnature Discovery Recent Developments
  19. 8.4 Charles River
  20. 8.4.1 Charles River Company Information
  21. 8.4.2 Charles River Business Overview
  22. 8.4.3 Charles River Virtual Screening Technology Service Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Charles River Virtual Screening Technology Service Product Portfolio
  24. 8.4.5 Charles River Recent Developments
  25. 8.5 Pharmaron
  26. 8.5.1 Pharmaron Company Information
  27. 8.5.2 Pharmaron Business Overview
  28. 8.5.3 Pharmaron Virtual Screening Technology Service Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Pharmaron Virtual Screening Technology Service Product Portfolio
  30. 8.5.5 Pharmaron Recent Developments
  31. 8.6 Evotec
  32. 8.6.1 Evotec Company Information
  33. 8.6.2 Evotec Business Overview
  34. 8.6.3 Evotec Virtual Screening Technology Service Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Evotec Virtual Screening Technology Service Product Portfolio
  36. 8.6.5 Evotec Recent Developments
  37. 8.7 Cresset Group
  38. 8.7.1 Cresset Group Company Information
  39. 8.7.2 Cresset Group Business Overview
  40. 8.7.3 Cresset Group Virtual Screening Technology Service Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Cresset Group Virtual Screening Technology Service Product Portfolio
  42. 8.7.5 Cresset Group Recent Developments
  43. 8.8 BioSoIvelT
  44. 8.8.1 BioSoIvelT Company Information
  45. 8.8.2 BioSoIvelT Business Overview
  46. 8.8.3 BioSoIvelT Virtual Screening Technology Service Revenue and Gross Margin (2021-2026)
  47. 8.8.4 BioSoIvelT Virtual Screening Technology Service Product Portfolio
  48. 8.8.5 BioSoIvelT Recent Developments
  49. 8.9 Enamine
  50. 8.9.1 Enamine Company Information
  51. 8.9.2 Enamine Business Overview
  52. 8.9.3 Enamine Virtual Screening Technology Service Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Enamine Virtual Screening Technology Service Product Portfolio
  54. 8.9.5 Enamine Recent Developments
  55. 8.10 Aurigene Services
  56. 8.10.1 Aurigene Services Company Information
  57. 8.10.2 Aurigene Services Business Overview
  58. 8.10.3 Aurigene Services Virtual Screening Technology Service Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Aurigene Services Virtual Screening Technology Service Product Portfolio
  60. 8.10.5 Aurigene Services Recent Developments
  61. 8.11 Selvita
  62. 8.11.1 Selvita Company Information
  63. 8.11.2 Selvita Business Overview
  64. 8.11.3 Selvita Virtual Screening Technology Service Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Selvita Virtual Screening Technology Service Product Portfolio
  66. 8.11.5 Selvita Recent Developments
  67. 8.12 HITS
  68. 8.12.1 HITS Company Information
  69. 8.12.2 HITS Business Overview
  70. 8.12.3 HITS Virtual Screening Technology Service Revenue and Gross Margin (2021-2026)
  71. 8.12.4 HITS Virtual Screening Technology Service Product Portfolio
  72. 8.12.5 HITS Recent Developments
  73. 8.13 Standigm
  74. 8.13.1 Standigm Company Information
  75. 8.13.2 Standigm Business Overview
  76. 8.13.3 Standigm Virtual Screening Technology Service Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Standigm Virtual Screening Technology Service Product Portfolio
  78. 8.13.5 Standigm Recent Developments
  79. 8.14 Syntekabio
  80. 8.14.1 Syntekabio Company Information
  81. 8.14.2 Syntekabio Business Overview
  82. 8.14.3 Syntekabio Virtual Screening Technology Service Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Syntekabio Virtual Screening Technology Service Product Portfolio
  84. 8.14.5 Syntekabio Recent Developments
  85. 8.15 Pharmacelera
  86. 8.15.1 Pharmacelera Company Information
  87. 8.15.2 Pharmacelera Business Overview
  88. 8.15.3 Pharmacelera Virtual Screening Technology Service Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Pharmacelera Virtual Screening Technology Service Product Portfolio
  90. 8.15.5 Pharmacelera Recent Developments
  91. 8.16 Receptor.AI
  92. 8.16.1 Receptor.AI Company Information
  93. 8.16.2 Receptor.AI Business Overview
  94. 8.16.3 Receptor.AI Virtual Screening Technology Service Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Receptor.AI Virtual Screening Technology Service Product Portfolio
  96. 8.16.5 Receptor.AI Recent Developments
  97. 8.17 Chemspace
  98. 8.17.1 Chemspace Company Information
  99. 8.17.2 Chemspace Business Overview
  100. 8.17.3 Chemspace Virtual Screening Technology Service Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Chemspace Virtual Screening Technology Service Product Portfolio
  102. 8.17.5 Chemspace Recent Developments
  103. 8.18 Jubilant Biosys
  104. 8.18.1 Jubilant Biosys Company Information
  105. 8.18.2 Jubilant Biosys Business Overview
  106. 8.18.3 Jubilant Biosys Virtual Screening Technology Service Revenue and Gross Margin (2021-2026)
  107. 8.18.4 Jubilant Biosys Virtual Screening Technology Service Product Portfolio
  108. 8.18.5 Jubilant Biosys Recent Developments
  109. 8.19 Aragen
  110. 8.19.1 Aragen Company Information
  111. 8.19.2 Aragen Business Overview
  112. 8.19.3 Aragen Virtual Screening Technology Service Revenue and Gross Margin (2021-2026)
  113. 8.19.4 Aragen Virtual Screening Technology Service Product Portfolio
  114. 8.19.5 Aragen Recent Developments
  115. 8.20 Domainex
  116. 8.20.1 Domainex Company Information
  117. 8.20.2 Domainex Business Overview
  118. 8.20.3 Domainex Virtual Screening Technology Service Revenue and Gross Margin (2021-2026)
  119. 8.20.4 Domainex Virtual Screening Technology Service Product Portfolio
  120. 8.20.5 Domainex Recent Developments
  121. 8.21 NUVISAN
  122. 8.21.1 NUVISAN Company Information
  123. 8.21.2 NUVISAN Business Overview
  124. 8.21.3 NUVISAN Virtual Screening Technology Service Revenue and Gross Margin (2021-2026)
  125. 8.21.4 NUVISAN Virtual Screening Technology Service Product Portfolio
  126. 8.21.5 NUVISAN Recent Developments
  127. 8.22 Concept Life Sciences
  128. 8.22.1 Concept Life Sciences Company Information
  129. 8.22.2 Concept Life Sciences Business Overview
  130. 8.22.3 Concept Life Sciences Virtual Screening Technology Service Revenue and Gross Margin (2021-2026)
  131. 8.22.4 Concept Life Sciences Virtual Screening Technology Service Product Portfolio
  132. 8.22.5 Concept Life Sciences Recent Developments
  133. 8.23 Schrödinger
  134. 8.23.1 Schrödinger Company Information
  135. 8.23.2 Schrödinger Business Overview
  136. 8.23.3 Schrödinger Virtual Screening Technology Service Revenue and Gross Margin (2021-2026)
  137. 8.23.4 Schrödinger Virtual Screening Technology Service Product Portfolio
  138. 8.23.5 Schrödinger Recent Developments
  139. 8.24 Cadence
  140. 8.24.1 Cadence Company Information
  141. 8.24.2 Cadence Business Overview
  142. 8.24.3 Cadence Virtual Screening Technology Service Revenue and Gross Margin (2021-2026)
  143. 8.24.4 Cadence Virtual Screening Technology Service Product Portfolio
  144. 8.24.5 Cadence Recent Developments
  145. 8.25 WuXi AppTec
  146. 8.25.1 WuXi AppTec Company Information
  147. 8.25.2 WuXi AppTec Business Overview
  148. 8.25.3 WuXi AppTec Virtual Screening Technology Service Revenue and Gross Margin (2021-2026)
  149. 8.25.4 WuXi AppTec Virtual Screening Technology Service Product Portfolio
  150. 8.25.5 WuXi AppTec Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst